Results 61 to 70 of about 18,628 (145)

Research progress of drug eluting balloon in arterial circulatory system

Frontiers in Cardiovascular Medicine
The arterial circulatory system diseases are common in clinical practice, and their treatment options have been of great interest due to their high morbidity and mortality.
Keji Lu, Keji Lu, Xianglin Ye, Xianglin Ye, Yaoxuan Chen, Peng Wang, Meiting Gong, Bing Xuan, Zhaobing Tang, Meiling Li, Jun Hou, Ke Peng, Haifeng Pei, Haifeng Pei   +13 more
doaj   +1 more source

Efficacy and Safety of Intracoronary Mesenchymal Stem Cell Administration in ST‐Segment Elevation Acute Myocardial Infarction: A Meta‐Analysis of Randomized Controlled Trials

Clinical and Translational Science, Volume 19, Issue 8, August 2026.
ABSTRACT ST‐segment elevation myocardial infarction (STEMI) remains a major cause of cardiovascular mortality and morbidity worldwide. Despite advances in reperfusion therapy, many patients still develop irreversible myocardial injury and adverse ventricular remodeling. Intracoronary mesenchymal stem cell (MSC) administration has been investigated as a
Kaiming Chen, Shijie Zhao, Xiaoqian Zou, Zhaoshuang Zhong, Shuyue Xia   +4 more
wiley   +1 more source

A drug-free cardiovascular stent functionalized with tailored collagen supports in-situ healing of vascular tissues

Nature Communications
Drug-eluting stent implantation suppresses the excessive proliferation of smooth muscle cells to reduce in-stent restenosis. However, the efficacy of drug-eluting stents remains limited due to delayed reendothelialization, impaired intimal remodeling ...
Haoshuang Wu, Li Yang, Rifang Luo, Li Li, Tiantian Zheng, Kaiyang Huang, Yumei Qin, Xia Yang, Xingdong Zhang, Yunbing Wang   +9 more
doaj   +1 more source

Stent Fracture after Everolimus-Eluting Stent Implantation

Cardiology Research and Practice, 2011
Compared with bare-metal stents, drug-eluting stents (DES) have greatly reduced the risk of in-stent restenosis (ISR) by inhibiting neointimal growth. Nevertheless, DES are still prone to device failure, which may lead to cardiac events.
Ali S. Almasood, Xavier Freixa, Sohail Q. Khan, Peter H. Seidelin, Vladimír Džavík   +4 more
doaj   +1 more source

Everolimus-eluting stents: update on current clinical studies

Medical Devices: Evidence and Research, 2011
Dominic J Allocco, Anita A Joshi, Keith D DawkinsBoston Scientific Corporation, Natick, MA, USAAbstract: Everolimus-eluting stents (EES) have become the most commonly implanted coronary stents worldwide.
Allocco DJ, Joshi AA, Dawkins KD
doaj  

Retained Drug-eluting Stents and Recalcitrant Chronic Rhinosinusitis: A Case Report

Allergy & Rhinology, 2013
Corticosteroids are the mainstay of treatment for refractory chronic rhinosinusitis. The off-label use of steroid-eluting stents has increasingly gained popularity in functional endoscopic sinus surgery for decreasing postoperative inflammation and ...
Phayvanh P. Sjogren Ph.D., Noah P. Parker M.D., Holly C. Boyer M.D.   +2 more
doaj   +1 more source

Results of endovascular treatment of multivessel coronary artery disease in patients with the different stent types

RUDN Journal of Medicine, 2012
Long-term results of endovascular treatment of multivessel coronary artery disease by using different revascularization strategies were analyzed in 171 patients. Duration of follow up ranged from 12 to 18 months.
Ye R Khairutdinov, Z Kh Shugushev, D A Maximkin, A G Faibushevich, V Yu Baranovich, Yu V Tarichko   +5 more
doaj  

From Caging to Uncaging With Bioadaptors: A Novel Paradigm in Coronary Revascularization

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
The evolution of percutaneous coronary intervention has improved the outcomes of patients with coronary artery disease, but conventional drug‐eluting stents remain limited by late adverse events, reduced vessel compliance, and the inability to restore ...
Placido Maria Mazzone, Marco Spagnolo, Simone Finocchiaro, Maria Sara Mauro, Giacinto Di Leo, Davide Capodanno   +5 more
doaj   +1 more source

Promoting endothelial recovery and reducing neointimal hyperplasia using sequential-like release of acetylsalicylic acid and paclitaxel-loaded biodegradable stents

International Journal of Nanomedicine, 2014
Cheng-Hung Lee,1,2 Chia-Ying Yu,2 Shang-Hung Chang,1 Kuo-Chun Hung,1 Shih-Jung Liu,2 Chao-Jan Wang,3 Ming-Yi Hsu,3 I-Chang Hsieh,1 Wei-Jan Chen,1 Yu-Shien Ko,1 Ming-Shien Wen1 1Division of Cardiology, Department of Internal Medicine, Chang Gung Memorial
Lee CH, Yu CY, Chang SH, Hung KC, Liu SJ, Wang CJ, Hsu MY, Hsieh IC, Chen WJ, Ko YS, Wen MS   +10 more
doaj  

Coronary stent implantation links to the occurrence of eosinophilia and interstitial pneumonia: a case report and systematic review

BMC Pulmonary Medicine
Background Rapamycin has been extensively utilized for coating coronary artery stents to reduce the occurrence of restenosis, yet there has been limited research on the potential harms of rapamycin-eluting stents. Herein, We report a case of eosinophilia
Fuyun Zhang, Wei Wang, Yingwei Zhu, Yimin Mao, Tongsheng Wang, Pengfei Gao   +5 more
doaj   +1 more source